BCTX - Briacell Therapeutics Corp - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

Briacell Therapeutics Corp's activity chart (see below) currently has 5 price targets and 17 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 31.25% of the time, taking 147 days on average.

Most recent stock forecast was given by from HC WAINWRIGHT on 14-Oct-2025. First documented stock forecast 13-Feb-2022.

Best performing analysts who are covering BCTX - Briacell Therapeutics Corp:

Emily Bodnar

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 15-Feb-2022

$40

$40

1 years 1 months 7 days ago
(14-Oct-2025)

5/8 (62.5%)

$28.58 (250.26%)

294

Show more analysts

Please expand the browser size to see the chart

What is BCTX (Briacell Therapeutics Corp) average time for price targets to be met?

On average it took 147 days for the stock forecasts to be reached, with an average price target met ratio of 31.25%.

Which analyst most recently updated their price target on BCTX (Briacell Therapeutics Corp)?

Which analyst has the lowest performance score on BCTX (Briacell Therapeutics Corp) with a proven track record?

EMILY BODNAR

Which analyst has the most public recommendations on BCTX (Briacell Therapeutics Corp)?

has 0 price targets and 0 ratings on BCTX

Which analyst is the currently most bullish on BCTX (Briacell Therapeutics Corp)?

Emily Bodnar with the highest potential upside of $36.94

Which analyst is the currently most reserved on BCTX (Briacell Therapeutics Corp)?

Emily Bodnar with the lowest potential downside of $36.94
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?